Background Male breast cancer (BC) is rare, managed by extrapolation from female BC. The
International Male BC Program aims to better characterize and manage this disease. We …

Background Male breast cancer (MBC) is a rare disease accounting for approximately 1% of
all breast carcinomas. Presently treatment recommendations are derived from the standards …

Male breast cancer is rare, and experience of it in any single institution is limited. Our current
understanding regarding its biology, natural history, and treatment strategies has been …

Male breast cancer (MBC) is a rare condition that accounts for 0.1% of all male cancers. Our
current evidence base for treatment is derived from female breast cancer (FBC) patients …

Background. Due to its rarity, male breast cancer (mBC) remains an inadequately
characterized disease, and current evidence for treatment derives from female breast cancer …

Male breast cancer is a rare disease, accounting for less than 1% of all breast cancer
diagnoses worldwide. Most data on male breast cancer comes from small single-institution …

Male breast cancer (MaBC) is a rare clinical entity, which makes up approximately 1% of all
breast cancers. However, the incidence of MaBC has been steadily increasing over the past …

Background Male breast cancer (MBC) is a rare disease for which there is limited
understanding of treatment patterns and prognostic factors. Methods Men with TNM stage I …

Male breast cancer (MBC) is rare. We assembled 446 MBCs on tissue microarrays and
assessed clinicopathological information, together with data from 15 published studies …

Aim Several prognostic histological features have been established in female breast cancer
(BC), but it is unknown whether these can be extrapolated to male BC patients. The aim of …